• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CareMax Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    10/15/24 6:55:08 AM ET
    $CMAX
    Hospital/Nursing Management
    Health Care
    Get the next $CMAX alert in real time by email
    8-K
    false00018139140001813914us-gaap:CommonClassAMember2024-10-142024-10-1400018139142024-10-142024-10-140001813914cmax:WarrantsMember2024-10-142024-10-14

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): October 14, 2024

     

    img232204206_0.jpg

     

     

    CareMax, Inc.

    (Exact name of Registrant as Specified in Its Charter)

     

     

    Delaware

    001-39391

    85-0992224

    (State or Other Jurisdiction
    of Incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

     

     

     

     

     

    1000 NW 57th Court

    Suite 400

     

    Miami, Florida

     

    33126

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 786 360-4768

     

     

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:


    Title of each class

     

    Trading
    Symbol(s)

     


    Name of each exchange on which registered

    Class A common stock, par value $0.0001 per share

     

    CMAX

     

    The Nasdaq Stock Market LLC

    Warrants, each whole warrant exercisable for 1/30th of one share of Class A common stock

     

    CMAXW

     

    The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☒


    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


    Item 1.01 Entry into a Material Definitive Agreement.

    On October 14, 2024, the Required Lenders under that certain Credit Agreement, dated as of May 10, 2022 (as amended, the “Credit Agreement”), by and among CareMax, Inc., a Delaware corporation (the “Company”), certain of the Company’s subsidiaries as guarantors, Jefferies Finance LLC, as Administrative Agent, Collateral Agent, Sole Lead Arranger and Bookrunner, BlackRock Financial Management (as defined in the Credit Agreement), as Lead Manager, Crestline Direct Finance, L.P., as Documentation Agent, and the lenders from time to time party thereto agreed to extend (i) the previously disclosed waiver of certain events of default under the Credit Agreement and (ii) the Third Amendment Specified Period (as defined in the Credit Agreement) through October 28, 2024, subject to an earlier termination of the waiver upon the occurrence of certain specified events.

    Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

    The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

     

     

     

     

     

    Date:

    October 15, 2024

    By:

    /s/ Kevin Wirges

     

     

     

    Name: Kevin Wirges
    Title: Executive Vice President, Chief Financial Officer and Treasurer
     

     


    Get the next $CMAX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CMAX

    DatePrice TargetRatingAnalyst
    2/26/2024$1.50 → $7.50Buy → Hold
    Jefferies
    11/17/2023$5.00 → $1.00Buy → Neutral
    UBS
    11/10/2023$3.00 → $2.00Overweight → Neutral
    Piper Sandler
    3/17/2023$7.00 → $4.00Outperform → Market Perform
    TD Cowen
    9/7/2022$7.50Hold
    Truist
    1/7/2022$14.00Buy
    UBS
    10/20/2021$15.00Buy
    Jefferies
    9/13/2021$14.00Neutral → Overweight
    Piper Sandler
    More analyst ratings